{
    "organizations": [],
    "uuid": "d253e09184596001e33b0d84c7b1ebbba2e0eaba",
    "author": "",
    "url": "https://www.reuters.com/article/brief-siga-technologies-announces-fda-ac/brief-siga-technologies-announces-fda-accepts-nda-and-grants-priority-review-for-oral-tpoxx-to-treat-smallpox-idUSASB0C4FZ",
    "ord_in_thread": 0,
    "title": "BRIEF-SIGA Technologies Announces FDA Accepts NDA And Grants Priority Review For Oral TPOXX To Treat Smallpox",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": " 39 PM / in 10 minutes BRIEF-SIGA Technologies Announces FDA Accepts NDA And Grants Priority Review For Oral TPOXX To Treat Smallpox Reuters Staff 1 Min Read \nFeb 7 (Reuters) - SIGA Technologies Inc: \n* SIGA TECHNOLOGIES ANNOUNCES FDA ACCEPTS NDA AND GRANTS PRIORITY REVIEW FOR ORAL TPOXX TO TREAT SMALLPOX Source text for Eikon: Further company coverage:",
    "published": "2018-02-07T14:37:00.000+02:00",
    "crawled": "2018-02-07T14:52:55.003+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "pm",
        "minute",
        "technology",
        "announces",
        "fda",
        "accepts",
        "nda",
        "grant",
        "priority",
        "review",
        "oral",
        "tpoxx",
        "treat",
        "smallpox",
        "reuters",
        "staff",
        "min",
        "read",
        "feb",
        "reuters",
        "siga",
        "technology",
        "inc",
        "siga",
        "technology",
        "announces",
        "fda",
        "accepts",
        "nda",
        "grant",
        "priority",
        "review",
        "oral",
        "tpoxx",
        "treat",
        "smallpox",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}